European Union could green light two COVID-19 vaccines in December
The European Union (EU) could give the green light to the COVID-19 vaccines being developed by Moderna and Pfizer/ BioNTech in December. European Commission President Ursula von der Leyen said on Thursday that the vaccines could be approved before the end of the year, which would allow them to be distributed in Europe.
“If all the procedures go smoothly, the EMA could give the Pfizer/BioNTech and Moderna vaccines their conditional marketing authorization as early as the second half of December,” Von Der Leyen said.
The European Commission has so far signed five contracts to pre-order potential vaccines: with Swedish-British company AstraZenaca, US company Johnson & Johnson, Franco-British duo Sanofi-GSK, US-German duo Pfizer/BioNTech and Germany’s CureVac.
